CompletedNot Applicable

Expression of PARP-1 in Multiple Sclerosis Patients

Egypt80 participantsStarted 2021-08-01

Plain-language summary

This study will explore the expression of PARP-1 in optic neuritis of multiple sclerosis patients. The data will be collected from Sohag University hospital in the period from the start of August 2021 to the end of December 2021. The study protocol will be approved by the Scientific Research Ethical Committee, Faculty of Medicine, Sohag University.

Who can participate

Age range20 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with multiple sclerosis with or without optic neuritis Multiple sclerosis will be diagnosed according to the McDonald criteria Exclusion Criteria: * • Isolated optic neuritis.

What they're measuring

measure PARP-1 mRNA

Timeframe: 2 weeks

Trial details

NCT IDNCT05196425

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-30

View on ClinicalTrials.gov More Multiple Sclerosis trials